adMare BioInnovations
Venture studioVancouver · Pre-Seed–Series B
Investment thesis
adMare BioInnovations aims to position Canada as a global leader in life sciences by focusing on three pillars: building companies, building ecosystems, and building talent. Working alongside partners in government, academia, industry, and the investment community, it applies scientific and commercial expertise, specialized R&D infrastructure, and seed capital to grow strong life sciences ventures. Returns generated are reinvested back into the Canadian life sciences industry to ensure its long-term sustainability and to develop industry-ready talent.
Source: firm website, verified Aug 3, 2026.
What they invest in
from 7 of 8 portfolio companiesBiotech ×4Medical Devices ×3Healthtech ×2Impact & Social Good ×2SaaS ×2AI & Machine Learning ×1Cloud Computing ×1Digital Health ×1
HQs:Canada×4United States×1
Investments · 8 tracked
founders shown can be your intro pathFind Therapeutics is a clinical-stage biopharmaceutical company developing therapies to treat demyelinating diseases, particularly multiple sclerosis and related conditions affecting myelin repair.
BiotechLongevityMedical DevicesMontreal, CA
Co-investorsCTI Life Sciences Fund L.P.
Thryv Therapeutics is a clinical-stage biotechnology company developing selective inhibitors of serum glucocorticoid inducible kinase 1 (SGK1) for inherited cardiac arrhythmias such as Long QT Syndrome and acquired cardiometabolic diseases.
BiotechHealthtechMedical Devices
Paul F. Truex(Chairman of the Board & Chief Executive Officer)inDebra OdinkinAmy Sehnertin
Co-investorsAmzak HealthAlexandriaCTI Life Sciences Fund L.P.Lumira Ventures
Thryv Therapeutics is a clinical-stage biotech developing precision-medicine treatments for genetic arrhythmia syndromes and acquired cardiometabolic diseases using selective inhibitors of serum glucocorticoid inducible kinase 1 (SGK1).
BiotechDigital HealthMedical Devices
Paul F. Truex(Chairman of the Board & Chief Executive Officer)inDebra Odink(President & Chief Development Officer)inAmy Sehnert(Chief Medical Officer)inMatt Killeen(Chief Business Officer)in
BoardSaumya Das(Chief Scientific Advisor)
Co-investorsLumira VenturesAmzak HealthCTI Life Sciences Fund L.P.Fonds de solidarité FTQ
A company built within adMare focused on developing early-stage technologies in a high-potential drug development area, with a proven founding executive and scientific team.
ADP provides cloud-based human capital management solutions that integrate payroll, HR, talent management, time and attendance, tax, and benefits administration for businesses globally.
Cloud ComputingEnterprise SoftwareHR TechSaaSRoseland, US
Co-investorsADP VenturesBraemont CapitalValor Equity Partners
Epitopea develops off-the-shelf cancer vaccines targeting aberrantly expressed tumor-specific antigens using its proprietary CryptoMap platform.
AI & Machine LearningBiotechHealthtechMontreal, CA
Claude PerreaultPierre Thibault
Co-investorsAdvent Life SciencesCambridge Innovation CapitalCTI Life Sciences Fund L.P.Fonds de solidarité FTQ
Portfolio news
latest coverage across their companiesFrequently asked questions
- What stage does adMare BioInnovations invest at?
- adMare BioInnovations invests at the Pre-Seed, Seed, Series A, Series B stages.
- What sectors does adMare BioInnovations focus on?
- adMare BioInnovations focuses on Biotech, Healthtech, IoT, Medical Devices.
- Where is adMare BioInnovations located?
- adMare BioInnovations is headquartered in Vancouver, CA.
- Who does adMare BioInnovations co-invest with?
- adMare BioInnovations most often shares deals with ADP Ventures, Braemont Capital, Valor Equity Partners, among 3 tracked co-investors.
Media · Podcasts & interviews
from their channelADMARE'S CROSS-CANADA VIRTUAL ROADTRIP - British Columbia Stop
adMare BioInnovations
CIHR webinar - Team Grant : Preparation to Trial: Inflammation for Chronic Conditions
adMare BioInnovations
CARI Webinar
adMare BioInnovations
adMare Academy Community - Getting Started Basic Navigation
adMare BioInnovations
What is the Executive Institute?
adMare BioInnovations
Images
Similar investors
Ambix is a healthcare-focused investment firm that provides funding, strategy, and hands-on support to companies developing medical tools and devices, biochemistry-based technologies, digital health applications, and other novel healthcare solutions. It invests across all stages and also builds companies itself.
LIFTT is a venture capital holding company focused on deep tech technologies, using an operational, multi-vertical approach aimed at generating impact. It works to transform scientific research into high-impact companies, accelerating the path from lab to market.
StarChain Ventures is an AI, data intelligence and blockchain-focused venture fund that backs founders building high-growth startups in high-stakes industries such as finance, healthcare, and supply chain. It also offers founder advisory ('Office Hours') and executive briefings for enterprise leaders.
Skolkovo is Russia's largest innovation center, supporting high-tech startups across industry, medicine, transport, and IT through acceleration programs, investor and university startup support, patenting, and export/import services. It operates the Skolkovo Technopark and the Skoltech institute.
Asahi Kasei Corporate Venture Capital, established in 2008, invests in innovative global companies across materials, homes, and healthcare sectors. The firm identifies strategic opportunities aligned with Asahi Kasei's core business, with offices in Menlo Park, Boston, Düsseldorf, and Shanghai.